rs148798048

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_198253.3(TERT):​c.779G>A​(p.Gly260Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000208 in 1,584,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G260G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

TERT
NM_198253.3 missense

Scores

1
5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:2

Conservation

PhyloP100: -2.00

Publications

4 publications found
Variant links:
Genes affected
TERT (HGNC:11730): (telomerase reverse transcriptase) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
TERT Gene-Disease associations (from GenCC):
  • pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • dyskeratosis congenita, autosomal dominant 2
    Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • dyskeratosis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hoyeraal-Hreidarsson syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • melanoma, cutaneous malignant, susceptibility to, 9
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04089123).
BP6
Variant 5-1294107-C-T is Benign according to our data. Variant chr5-1294107-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 471902.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TERTNM_198253.3 linkc.779G>A p.Gly260Asp missense_variant Exon 2 of 16 ENST00000310581.10 NP_937983.2 O14746-1
TERTNM_001193376.3 linkc.779G>A p.Gly260Asp missense_variant Exon 2 of 15 NP_001180305.1 O14746-3
TERTNR_149162.3 linkn.858G>A non_coding_transcript_exon_variant Exon 2 of 13
TERTNR_149163.3 linkn.858G>A non_coding_transcript_exon_variant Exon 2 of 13

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TERTENST00000310581.10 linkc.779G>A p.Gly260Asp missense_variant Exon 2 of 16 1 NM_198253.3 ENSP00000309572.5 O14746-1
TERTENST00000334602.10 linkc.779G>A p.Gly260Asp missense_variant Exon 2 of 15 1 ENSP00000334346.6 O14746-3
TERTENST00000460137.6 linkn.779G>A non_coding_transcript_exon_variant Exon 2 of 13 1 ENSP00000425003.1 O14746-4
TERTENST00000656021.1 linkn.779G>A non_coding_transcript_exon_variant Exon 2 of 17 ENSP00000499759.1 A0A590UK92

Frequencies

GnomAD3 genomes
AF:
0.0000854
AC:
13
AN:
152234
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000685
AC:
13
AN:
189802
AF XY:
0.0000383
show subpopulations
Gnomad AFR exome
AF:
0.00118
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000140
AC:
20
AN:
1432664
Hom.:
0
Cov.:
35
AF XY:
0.0000183
AC XY:
13
AN XY:
711184
show subpopulations
African (AFR)
AF:
0.000397
AC:
13
AN:
32706
American (AMR)
AF:
0.00
AC:
0
AN:
41908
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25706
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37746
South Asian (SAS)
AF:
0.0000241
AC:
2
AN:
83066
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46362
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5746
European-Non Finnish (NFE)
AF:
9.09e-7
AC:
1
AN:
1100106
Other (OTH)
AF:
0.0000506
AC:
3
AN:
59318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000854
AC:
13
AN:
152234
Hom.:
0
Cov.:
34
AF XY:
0.0000403
AC XY:
3
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41470
American (AMR)
AF:
0.0000654
AC:
1
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000252
Hom.:
0
Bravo
AF:
0.000178
ESP6500AA
AF:
0.000918
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000586
AC:
7

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 14, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed in individuals with aplastic anemia or neuroblastoma (PMID: 19674077, 26580448, 30523342); Published functional studies demonstrate no damaging effect: no impact on telomere overhang length or binding with BRG-1 and beta-catenin (PMID: 19674077, 24983628); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 19674077, 24983628, 23716176, 30791107, 30523342, 26580448) -

Dyskeratosis congenita Uncertain:1Benign:1
Nov 22, 2021
Sema4, Sema4
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Aug 29, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Acute myeloid leukemia;C3151443:Dyskeratosis congenita, autosomal dominant 2;C3553617:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1;C3554574:Melanoma, cutaneous malignant, susceptibility to, 9 Uncertain:1
Jun 08, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aplastic anemia Uncertain:1
Feb 13, 2023
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TERT-related disorder Uncertain:1
Aug 19, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The TERT c.779G>A variant is predicted to result in the amino acid substitution p.Gly260Asp. This variant has been reported in a 73 year old individual with acquired aplastic anemia (Calado et al. 2009. PubMed ID: 19674077), in an individual with neuroblastoma (TableS4b, Zhang et al. 2015. PubMed ID: 26580448), and in an individual with telomere disease (Kapuria et al. 2019. PubMed ID: 30791107). Functional studies have shown that this variant has no impact on telomere overhang length or protein binding (Calado et al. 2009. PubMed ID: 19674077; Zhang et al. 2014. PubMed ID: 24983628). This variant is reported in 0.071% of alleles in individuals of African descent in gnomAD. This variant has conflicting interpretations in ClinVar regarding is pathogenicity, ranging from uncertain to benign (https://www.ncbi.nlm.nih.gov/clinvar/variation/471902). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Benign:1
Aug 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
-0.040
CADD
Benign
0.33
DANN
Benign
0.27
DEOGEN2
Uncertain
0.42
T;.
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.49
T;T
M_CAP
Pathogenic
0.64
D
MetaRNN
Benign
0.041
T;T
MetaSVM
Uncertain
-0.014
T
MutationAssessor
Benign
0.55
N;N
PhyloP100
-2.0
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.42
N;N
REVEL
Uncertain
0.56
Sift
Benign
0.79
T;T
Sift4G
Benign
0.34
T;T
Polyphen
0.0010
B;B
Vest4
0.078
MVP
0.99
MPC
1.3
ClinPred
0.0068
T
GERP RS
-3.7
Varity_R
0.10
gMVP
0.52
Mutation Taster
=1/99
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148798048; hg19: chr5-1294222; API